GLP-1 Therapy

Authoritative sources

• No external identifiers on record.

Evidence base

• Systematic Review · 2026

  Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review

  Disease-a-month : DM · Gunasekaran P, Inban P, Agrawal A, Thai A, et al.

• Randomized Controlled Trial · 2026

  Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial

  Diabetes, obesity & metabolism · Heise T, Zijlstra E, Mari A, Roell WC, et al.

• Meta-Analysis · 2026

  Differential impact of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss in the type 2 diabetic and non-diabetic populations

  Surgical endoscopy · Jia IT, Bloomfield GC, Chen MY, Cunningham MH, et al.

• Meta-Analysis · 2025

  Effect of GLP-1 agonists on testosterone levels: a systematic review and meta-analysis

  BMC urology · Orra SH, Martinez JVN, Porto BC, Passerotti CC, et al.

• Randomized Controlled Trial · 2024

  GLP-1 therapy increases visceral adipose tissue metabolic activity: lessons from a randomized controlled trial in obstructive sleep apnea

  Obesity (Silver Spring, Md.) · O'Donnell C, Ryan O, Hogan AE, Killick D, et al.

• Meta-Analysis · 2023

  Glucagon-Like Peptide 1 Analogues as Adjunctive Therapy for Patients With Type 1 Diabetes: An Updated Systematic Review and Meta-analysis

  The Journal of clinical endocrinology and metabolism · Park J, Ntelis S, Yunasan E, Downton KD, et al.

• Meta-Analysis · 2022

  Effect of glucagon-like peptide-1 (GLP-1) analogues on epicardial adipose tissue: A meta-analysis

  Diabetes & metabolic syndrome · Berg G, Barchuk M, Lobo M, Nogueira JP

• Meta-Analysis · 2022

  Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials

  BMC endocrine disorders · Qin J, Song L

• Meta-Analysis · 2021

  GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

  Canadian journal of gastroenterology & hepatology · Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, Jalali M, et al.

Where GLP-1 Therapy appears on Kindr Health